What is Clinical Trial Optimization?
Our SaaS based tool accesses claims integrated EMR data on nearly 30% of actively treated cancer patients across 900+ provider sites in the United States. This data can be queried by treatment, care standards, racial and ethnic diversity, lines of therapy, and outcomes in very sophisticated approaches. It answers questions on the impact of study design and site selection by looking at cohort characteristics, racial and ethnic diversity, burden on the patient, and projected enrollment.
Our SaaS solution enables you to:
Assess Study Feasibility
Select Optimal Sites
Evaluate Protocol Eligibility Criteria
Dynamically Assess Trial Enrollment Feasibility & Select Optimal Sites
“Our Feasibility team would stage a coup if we stopped license, in a short time you have become a critical part of our clinical research site selection process”
– CRO Client
“We have our current go-to trial feasibility solution, but discovered that your software and data is a much better fit for our Oncology trials feasibility needs”
– Large Pharma Client
Key Benefits
Gain AI-driven Insights into Study Feasibility and Operations
Site Selection for Trials Based on AI Models of Retrospective RWD
Review Racial and Ethnic Compositions of Site-level Patient Cohorts
Historical trends & AI-driven prediction of future performance of study at sites
Over 900 US site locations with deep Oncology, Hematology & Urology patient data
Evaluate patient & site burden of protocol against standard of care and other treatment pathways
Our network of sites includes many community cancer centers with high diversity